Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089929 · ClinicalTrials.gov registry record
Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 55
- Enrollment target
NCT05089929 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 55 participants.
The verdict
NCT05089929 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD). This device allows the clinician to measure muscle activity in the esophagus during a routine upper endoscopy. The FLIP topography will be used to help detect movement disorders in the esophagus, and to examine differences in patient satisfaction between FLIP topography and the standard of care procedure, high resolution manometry (HRM).
Interventions
- DEVICE Endoflip 2.0
- PROCEDURE High Resolution Manometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2020-03-19 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05089929
The ClinicalTrials.gov registry entry for NCT05089929 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endoflip 2.0 is the first listed.
NCT05089929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05089929 about?
NCT05089929 is a clinical study titled "Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)". The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD). This device allows the clinician to measure muscle activity in the esophagus during a routine upper endoscopy. The FLIP topography will be used to help ...
What is the current status of trial NCT05089929?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2020-03-19. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05089929?
The interventions under investigation include: Endoflip 2.0 (DEVICE), High Resolution Manometry (PROCEDURE).
Who is sponsoring clinical trial NCT05089929?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.